Provided by Tiger Trade Technology Pte. Ltd.

Acumen Pharmaceuticals, Inc.

2.82
-0.1050-3.60%
Volume:158.47K
Turnover:445.29K
Market Cap:203.28M
PE:-1.72
High:2.92
Open:2.90
Low:2.76
Close:2.92
52wk High:3.60
52wk Low:1.21
Shares:72.21M
Float Shares:37.05M
Volume Ratio:0.72
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6370
EPS(LYR):-2.0035
ROE:-120.50%
ROA:-45.77%
PB:3.55
PE(LYR):-1.41

Loading ...

Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025

Major Issues Report

Form 8-K - Current report